Clinical Study of Genakumab for Injection in Patients With Acute Gout

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

May 22, 2021

Primary Completion Date

June 9, 2022

Study Completion Date

June 9, 2022

Conditions
Acute Gout
Interventions
DRUG

Genakumab for Injection

150 mg/1ml/bottle

DRUG

Placebo for Genakumab for Injection

The placebo contains other excipients except Genakumab, and its appearance is consistent with that of Genakumab for injection

Trial Locations (1)

310000

Shanghai Huashan Hospital affiliated to Fudan University, Shanghai

All Listed Sponsors
collaborator

Huashan Hospital

OTHER

collaborator

Hainan General Hospital

OTHER

collaborator

Linyi People's Hospital

OTHER

collaborator

The Second Affiliated Hospital of Chongqing Medical University

OTHER

collaborator

Changhai Hospital

OTHER

collaborator

The First Affiliated Hospital with Nanjing Medical University

OTHER

collaborator

Shengjing Hospital

OTHER

collaborator

Affiliated Hospital of Nantong University

OTHER

lead

Changchun GeneScience Pharmaceutical Co., Ltd.

INDUSTRY